CBIA 0.00 Canopus BioPharma Incorporated
| Range: | 1.0E-4-0.0018 | Vol Avg: | 8628353 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.19 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Fri Dec 31 1999 | Empoloyees: | |||
| CUSIP: | 138034103 | CIK: | 0001404356 | ISIN: | US1380341032 | Country: | US |
| CEO: | Mr. Patrick T. Prendergast | Website: | https://www.blueheaven.cafe | ||||
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow